Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE47.9300
- TODAY'S CHANGE (%)-0.0700 (-0.1458%)
- Bid / Lots36.0000/ 2
- Ask / Lots50.0000/ 1
- Open / Previous Close48.1600 / 48.0000
- Day Range
- 52 Week Range
- Volume1,639,626
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 10233 | 48.48 |
| 09:34 ET | 35900 | 48.66 |
| 09:36 ET | 3000 | 48.745 |
| 09:38 ET | 1280 | 48.765 |
| 09:39 ET | 100 | 48.94 |
| 09:41 ET | 742 | 48.55 |
| 09:43 ET | 109793 | 48.68 |
| 09:48 ET | 800 | 48.78 |
| 09:50 ET | 1076 | 48.725 |
| 09:52 ET | 1524 | 48.58 |
| 09:54 ET | 1000 | 48.21 |
| 09:56 ET | 16000 | 48.29 |
| 09:57 ET | 2700 | 48.14 |
| 09:59 ET | 1100 | 48.05 |
| 10:01 ET | 1217 | 47.96 |
| 10:03 ET | 1314 | 47.95 |
| 10:06 ET | 2906 | 48.29 |
| 10:08 ET | 1643 | 48.39 |
| 10:10 ET | 100 | 48.355 |
| 10:12 ET | 600 | 48.32 |
| 10:14 ET | 200 | 48.32 |
| 10:15 ET | 723 | 48.27 |
| 10:17 ET | 400 | 48.28 |
| 10:19 ET | 400 | 48.3609 |
| 10:21 ET | 1455 | 48.485 |
| 10:24 ET | 400 | 48.55 |
| 10:26 ET | 1400 | 48.47 |
| 10:28 ET | 100 | 48.5 |
| 10:30 ET | 800 | 48.46 |
| 10:32 ET | 868 | 48.36 |
| 10:33 ET | 1400 | 48.5 |
| 10:35 ET | 200 | 48.53 |
| 10:37 ET | 1094 | 48.45 |
| 10:39 ET | 600 | 48.55 |
| 10:42 ET | 1200 | 48.42 |
| 10:44 ET | 700 | 48.25 |
| 10:46 ET | 300 | 48.11 |
| 10:48 ET | 800 | 48.12 |
| 10:51 ET | 300 | 48.02 |
| 10:53 ET | 1200 | 47.92 |
| 10:55 ET | 1233 | 47.99 |
| 10:57 ET | 800 | 47.955 |
| 11:00 ET | 200 | 47.975 |
| 11:02 ET | 400 | 48.04 |
| 11:04 ET | 100 | 48.06 |
| 11:06 ET | 2210 | 48.31 |
| 11:08 ET | 275 | 48.32 |
| 11:09 ET | 1100 | 48.29 |
| 11:11 ET | 20036 | 48.22 |
| 11:13 ET | 1808 | 48.14 |
| 11:15 ET | 600 | 47.94 |
| 11:18 ET | 400 | 48.015 |
| 11:20 ET | 200 | 47.95 |
| 11:22 ET | 1400 | 47.82 |
| 11:24 ET | 902 | 47.75 |
| 11:26 ET | 1172 | 47.89 |
| 11:27 ET | 400 | 47.78 |
| 11:29 ET | 1406 | 47.83 |
| 11:31 ET | 1000 | 47.74 |
| 11:33 ET | 200 | 47.75 |
| 11:36 ET | 200 | 47.8 |
| 11:38 ET | 29785 | 47.975 |
| 11:40 ET | 200 | 48.02 |
| 11:42 ET | 1000 | 47.85 |
| 11:44 ET | 700 | 47.75 |
| 11:45 ET | 200 | 47.75 |
| 11:47 ET | 200 | 47.71 |
| 11:49 ET | 800 | 47.735 |
| 11:51 ET | 1992 | 47.76 |
| 11:54 ET | 700 | 47.83 |
| 11:56 ET | 300 | 47.92 |
| 11:58 ET | 600 | 47.97 |
| 12:00 ET | 940 | 47.92 |
| 12:03 ET | 1019 | 47.945 |
| 12:07 ET | 600 | 47.925 |
| 12:09 ET | 2100 | 48.04 |
| 12:12 ET | 1100 | 47.92 |
| 12:18 ET | 700 | 48 |
| 12:20 ET | 200 | 47.98 |
| 12:23 ET | 200 | 47.94 |
| 12:25 ET | 900 | 47.94 |
| 12:27 ET | 1900 | 48 |
| 12:30 ET | 300 | 47.975 |
| 12:32 ET | 300 | 47.975 |
| 12:36 ET | 2257 | 48.005 |
| 12:38 ET | 200 | 47.96 |
| 12:39 ET | 1100 | 47.91 |
| 12:41 ET | 300 | 47.96 |
| 12:43 ET | 400 | 47.9201 |
| 12:45 ET | 200 | 47.95 |
| 12:48 ET | 500 | 47.98 |
| 12:50 ET | 200 | 47.96 |
| 12:52 ET | 200 | 47.98 |
| 12:54 ET | 700 | 47.97 |
| 12:56 ET | 500 | 47.96 |
| 12:57 ET | 500 | 47.98 |
| 12:59 ET | 2282 | 47.91 |
| 01:01 ET | 1000 | 47.82 |
| 01:03 ET | 500 | 47.77 |
| 01:06 ET | 400 | 47.785 |
| 01:08 ET | 700 | 47.78 |
| 01:10 ET | 1900 | 47.82 |
| 01:12 ET | 100 | 47.735 |
| 01:14 ET | 700 | 47.81 |
| 01:15 ET | 100 | 47.77 |
| 01:17 ET | 200 | 47.81 |
| 01:19 ET | 1104 | 47.8 |
| 01:21 ET | 500 | 47.745 |
| 01:24 ET | 500 | 47.67 |
| 01:26 ET | 100 | 47.71 |
| 01:28 ET | 1176 | 47.7075 |
| 01:30 ET | 100 | 47.71 |
| 01:32 ET | 1200 | 47.71 |
| 01:33 ET | 3758 | 47.47 |
| 01:35 ET | 200 | 47.48 |
| 01:37 ET | 5625 | 47.41 |
| 01:39 ET | 700 | 47.41 |
| 01:42 ET | 5505 | 47.3 |
| 01:44 ET | 1000 | 47.29 |
| 01:46 ET | 2989 | 47.23 |
| 01:48 ET | 748 | 47.17 |
| 01:50 ET | 1316 | 47.16 |
| 01:51 ET | 100 | 47.14 |
| 01:53 ET | 1996 | 47.22 |
| 01:55 ET | 500 | 47.25 |
| 01:57 ET | 300 | 47.2 |
| 02:00 ET | 1200 | 47.18 |
| 02:02 ET | 2165 | 46.96 |
| 02:04 ET | 970 | 46.92 |
| 02:06 ET | 2988 | 47.155 |
| 02:08 ET | 3965 | 47.15 |
| 02:09 ET | 10052 | 47.19 |
| 02:11 ET | 6234 | 47.25 |
| 02:13 ET | 41591 | 47.55 |
| 02:15 ET | 2365 | 47.7 |
| 02:18 ET | 600 | 47.6 |
| 02:20 ET | 2300 | 47.615 |
| 02:22 ET | 650 | 47.58 |
| 02:24 ET | 400 | 47.53 |
| 02:26 ET | 100 | 47.53 |
| 02:27 ET | 1000 | 47.55 |
| 02:29 ET | 795 | 47.55 |
| 02:31 ET | 1200 | 47.44 |
| 02:33 ET | 1300 | 47.58 |
| 02:36 ET | 100 | 47.62 |
| 02:38 ET | 300 | 47.7 |
| 02:40 ET | 1828 | 47.67 |
| 02:42 ET | 400 | 47.63 |
| 02:44 ET | 300 | 47.665 |
| 02:45 ET | 3616 | 47.81 |
| 02:47 ET | 700 | 47.94 |
| 02:49 ET | 200 | 47.95 |
| 02:51 ET | 1986 | 47.91 |
| 02:54 ET | 200 | 47.905 |
| 02:56 ET | 1100 | 47.85 |
| 02:58 ET | 5870 | 47.58 |
| 03:00 ET | 2200 | 47.43 |
| 03:02 ET | 11737 | 47.31 |
| 03:03 ET | 6773 | 47.67 |
| 03:05 ET | 1903 | 47.63 |
| 03:07 ET | 403 | 47.61 |
| 03:09 ET | 1254 | 47.61 |
| 03:12 ET | 1275 | 47.72 |
| 03:14 ET | 2103 | 47.565 |
| 03:16 ET | 700 | 47.62 |
| 03:18 ET | 600 | 47.6 |
| 03:20 ET | 2348 | 47.605 |
| 03:21 ET | 900 | 47.57 |
| 03:23 ET | 750 | 47.67 |
| 03:25 ET | 4247 | 47.68 |
| 03:27 ET | 3613 | 47.58 |
| 03:30 ET | 1362 | 47.545 |
| 03:32 ET | 1700 | 47.45 |
| 03:34 ET | 2500 | 47.59 |
| 03:36 ET | 1039 | 47.6 |
| 03:38 ET | 1109 | 47.64 |
| 03:39 ET | 2000 | 47.635 |
| 03:41 ET | 5044 | 47.8 |
| 03:43 ET | 700 | 47.85 |
| 03:45 ET | 4847 | 47.92 |
| 03:48 ET | 3639 | 48.075 |
| 03:50 ET | 4995 | 47.95 |
| 03:52 ET | 9782 | 47.85 |
| 03:54 ET | 4475 | 47.96 |
| 03:56 ET | 13919 | 47.755 |
| 03:57 ET | 17050 | 47.93 |
| 03:59 ET | 40491 | 47.93 |
May 10, 2024
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:38PM ET on Friday May 10, 2024 by Dow Jones
5:38PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 3:50PM ET on Friday May 10, 2024 by Dow Jones
3:50PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 12:55PM ET on Friday May 10, 2024 by Dow Jones
12:55PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:06PM ET on Thursday May 09, 2024 by Dow Jones
4:06PM ET on Thursday May 09, 2024 by Dow Jones*DJ Crinetics Pharmaceuticals 1Q Loss/Shr 93c >CRNX, from 4:06PM ET on Thursday May 09, 2024 by Dow Jones
4:06PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.8B | -12.7x | --- |
Nuvalent Inc | 4.2B | -27.4x | --- |
Immunovant Inc | 4.3B | -16.4x | --- |
Summit Therapeutics Inc | 3.3B | -3.1x | --- |
Madrigal Pharmaceuticals Inc | 4.4B | -9.2x | --- |
Biohaven Ltd | 3.1B | -6.0x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.8B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.7x |
Price/Sales (TTM) | 1,914.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
